# Yihua Huang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yihua-huang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 983 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 17 |
| i10-index | 26 |
| OpenAlex ID | https://openalex.org/A5090962174 |
| ORCID iD | 0000-0003-1890-0296 |
| Works | 120 |

## Researcher papers

- [EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer](https://scholariq.org/papers/egfr-exon-20-insertion-mutations-and-response-to-osimertinib-in-non-small-cell/)
- [PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy](https://scholariq.org/papers/pi3k-akt-mtor-pathway-alterations-in-advanced-nsclc-patients-after-progression/)
- [Simultaneous Liver and Colorectal Resections Are Safe for Synchronous Colorectal Liver Metastases](https://scholariq.org/papers/simultaneous-liver-and-colorectal-resections-are-safe-for-synchronous-colorectal-2/)
- [Treatment and Outcome of a Patient With Lung Cancer Infected With Severe Acute Respiratory Syndrome Coronavirus-2](https://scholariq.org/papers/treatment-and-outcome-of-a-patient-with-lung-cancer-infected-with-severe-acute/)
- [The hepatic senescence-associated secretory phenotype promotes hepatocarcinogenesis through Bcl3-dependent activation of macrophages](https://scholariq.org/papers/the-hepatic-senescence-associated-secretory-phenotype-promotes/)
- [EGFR Oncogenic Mutations in NSCLC Impair Macrophage Phagocytosis and Mediate Innate Immune Evasion Through Up-Regulation of CD47](https://scholariq.org/papers/egfr-oncogenic-mutations-in-nsclc-impair-macrophage-phagocytosis-and-mediate/)
- [Acquired BRAF V600E Mutation Mediated Resistance to Osimertinib and Responded to Osimertinib, Dabrafenib, and Trametinib Combination Therapy](https://scholariq.org/papers/acquired-braf-v600e-mutation-mediated-resistance-to-osimertinib-and-responded-to/)
- [Oncostatin M promotes hepatic progenitor cell activation and hepatocarcinogenesis via macrophage-derived tumor necrosis factor-α](https://scholariq.org/papers/oncostatin-m-promotes-hepatic-progenitor-cell-activation-and/)
- [Acquired EGFR L718V Mutation and Loss of T790M-Mediated Resistance to Osimertinib in a Patient With NSCLC Who Responded to Afatinib](https://scholariq.org/papers/acquired-egfr-l718v-mutation-and-loss-of-t790m-mediated-resistance-to/)
- [Research progress in immune checkpoint inhibitors for lung cancer in China](https://scholariq.org/papers/research-progress-in-immune-checkpoint-inhibitors-for-lung-cancer-in-china/)
- [Rare transformation from lung adenocarcinoma to sarcomatoid carcinoma mediates resistance to inhibitors targeting different driver oncogenes](https://scholariq.org/papers/rare-transformation-from-lung-adenocarcinoma-to-sarcomatoid-carcinoma-mediates/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.